 Michael Yeager
Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 22 | 2021 | 1904 | 2.230 |
Why?
| | Down Syndrome | 6 | 2024 | 491 | 1.920 |
Why?
| | Respiratory Tract Infections | 2 | 2024 | 396 | 1.240 |
Why?
| | Pulmonary Artery | 7 | 2021 | 1084 | 0.790 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 2 | 2021 | 18 | 0.740 |
Why?
| | Matrix Metalloproteinases | 2 | 2021 | 94 | 0.740 |
Why?
| | Ventricular Function | 1 | 2021 | 60 | 0.710 |
Why?
| | Fibroblasts | 6 | 2013 | 993 | 0.550 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2017 | 66 | 0.500 |
Why?
| | Vascular Stiffness | 1 | 2021 | 493 | 0.490 |
Why?
| | Blood Vessels | 2 | 2013 | 187 | 0.470 |
Why?
| | Biomarkers | 2 | 2015 | 4164 | 0.420 |
Why?
| | Lymphoid Tissue | 1 | 2013 | 75 | 0.410 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2012 | 445 | 0.390 |
Why?
| | Arteritis | 1 | 2012 | 28 | 0.370 |
Why?
| | Unfolded Protein Response | 1 | 2012 | 59 | 0.370 |
Why?
| | Lung | 6 | 2023 | 4067 | 0.370 |
Why?
| | Mesoderm | 2 | 2011 | 144 | 0.350 |
Why?
| | Precision Medicine | 1 | 2015 | 428 | 0.340 |
Why?
| | Proteomics | 2 | 2015 | 1108 | 0.340 |
Why?
| | Microsatellite Repeats | 2 | 2002 | 168 | 0.340 |
Why?
| | Phagocytes | 1 | 2011 | 100 | 0.340 |
Why?
| | Myeloid Cells | 1 | 2011 | 148 | 0.330 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 234 | 0.330 |
Why?
| | Blood Proteins | 1 | 2012 | 252 | 0.330 |
Why?
| | Lung Diseases | 1 | 2017 | 769 | 0.330 |
Why?
| | Endothelin-1 | 1 | 2012 | 182 | 0.330 |
Why?
| | Proteome | 1 | 2015 | 472 | 0.330 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2012 | 261 | 0.320 |
Why?
| | Immunoglobulin G | 1 | 2013 | 886 | 0.310 |
Why?
| | Endothelium, Vascular | 3 | 2002 | 927 | 0.260 |
Why?
| | Autoantibodies | 1 | 2013 | 1500 | 0.240 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 2113 | 0.220 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2002 | 59 | 0.220 |
Why?
| | Cytokines | 4 | 2017 | 2090 | 0.210 |
Why?
| | Child | 7 | 2024 | 21999 | 0.210 |
Why?
| | Biology | 1 | 2023 | 87 | 0.200 |
Why?
| | Interferons | 1 | 2024 | 202 | 0.190 |
Why?
| | Leukocytes | 1 | 2024 | 312 | 0.190 |
Why?
| | Flow Cytometry | 4 | 2019 | 1184 | 0.190 |
Why?
| | Disease Models, Animal | 4 | 2023 | 4284 | 0.180 |
Why?
| | Histone Deacetylase Inhibitors | 2 | 2013 | 210 | 0.180 |
Why?
| | Humans | 24 | 2024 | 137294 | 0.170 |
Why?
| | Proto-Oncogene Proteins | 2 | 2002 | 647 | 0.170 |
Why?
| | Arterial Pressure | 1 | 2021 | 125 | 0.170 |
Why?
| | Gene Expression | 2 | 2024 | 1501 | 0.170 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1501 | 0.170 |
Why?
| | Male | 14 | 2023 | 67560 | 0.150 |
Why?
| | Interferon-alpha | 1 | 2019 | 198 | 0.150 |
Why?
| | Rats | 5 | 2013 | 5639 | 0.150 |
Why?
| | Prognosis | 2 | 2017 | 4026 | 0.150 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 69 | 0.140 |
Why?
| | MicroRNAs | 2 | 2015 | 699 | 0.140 |
Why?
| | Animals | 13 | 2023 | 36862 | 0.130 |
Why?
| | TRPM Cation Channels | 1 | 2017 | 74 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2017 | 3546 | 0.130 |
Why?
| | Histone Deacetylases | 3 | 2013 | 215 | 0.130 |
Why?
| | Blood Flow Velocity | 1 | 2017 | 412 | 0.130 |
Why?
| | Hemodynamics | 1 | 2021 | 1110 | 0.120 |
Why?
| | Magnetic Resonance Angiography | 1 | 2017 | 240 | 0.120 |
Why?
| | Rats, Wistar | 2 | 2013 | 455 | 0.120 |
Why?
| | Female | 11 | 2023 | 73052 | 0.120 |
Why?
| | Ventricular Function, Right | 1 | 2017 | 283 | 0.120 |
Why?
| | Gene Expression Profiling | 3 | 2013 | 1774 | 0.120 |
Why?
| | Atrial Natriuretic Factor | 1 | 2015 | 57 | 0.120 |
Why?
| | Cardiovascular System | 1 | 2017 | 139 | 0.120 |
Why?
| | Adolescent | 4 | 2021 | 21499 | 0.120 |
Why?
| | Inflammation | 4 | 2017 | 2836 | 0.120 |
Why?
| | Mutation | 4 | 2003 | 3956 | 0.120 |
Why?
| | Cell Proliferation | 2 | 2013 | 2479 | 0.120 |
Why?
| | Breath Tests | 1 | 2015 | 87 | 0.120 |
Why?
| | Heart Ventricles | 2 | 2017 | 792 | 0.110 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2015 | 101 | 0.110 |
Why?
| | Cause of Death | 1 | 2017 | 429 | 0.110 |
Why?
| | Chemokine CCL2 | 2 | 2013 | 115 | 0.110 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 71 | 0.110 |
Why?
| | Fluorescent Antibody Technique | 2 | 2011 | 388 | 0.110 |
Why?
| | Phenotype | 4 | 2017 | 3202 | 0.110 |
Why?
| | Angiotensin II | 1 | 2013 | 99 | 0.100 |
Why?
| | Vascular Remodeling | 1 | 2015 | 189 | 0.100 |
Why?
| | Receptors, Growth Factor | 2 | 2003 | 55 | 0.100 |
Why?
| | Cardiac Catheterization | 2 | 2017 | 528 | 0.100 |
Why?
| | Adventitia | 1 | 2012 | 40 | 0.100 |
Why?
| | Hypoxia | 4 | 2013 | 1111 | 0.100 |
Why?
| | Metalloporphyrins | 1 | 2013 | 103 | 0.100 |
Why?
| | Mice | 6 | 2023 | 17774 | 0.100 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2012 | 11 | 0.100 |
Why?
| | Activating Transcription Factor 6 | 1 | 2012 | 19 | 0.090 |
Why?
| | Polymerase Chain Reaction | 2 | 2013 | 1061 | 0.090 |
Why?
| | Endothelin A Receptor Antagonists | 1 | 2012 | 26 | 0.090 |
Why?
| | Receptor, Endothelin B | 1 | 2012 | 51 | 0.090 |
Why?
| | Bronchi | 1 | 2013 | 260 | 0.090 |
Why?
| | Monocytes | 2 | 2012 | 563 | 0.090 |
Why?
| | Echocardiography | 1 | 2015 | 659 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 851 | 0.090 |
Why?
| | Cell Movement | 2 | 2013 | 969 | 0.090 |
Why?
| | Receptor, Endothelin A | 1 | 2012 | 65 | 0.090 |
Why?
| | bcl-2-Associated X Protein | 2 | 2002 | 56 | 0.090 |
Why?
| | Inflammasomes | 1 | 2013 | 128 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 153 | 0.090 |
Why?
| | Leukocyte Common Antigens | 1 | 2011 | 87 | 0.090 |
Why?
| | Chemokine CXCL12 | 1 | 2011 | 81 | 0.090 |
Why?
| | Peptide Fragments | 1 | 2015 | 707 | 0.090 |
Why?
| | Fibrosis | 1 | 2013 | 552 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 186 | 0.090 |
Why?
| | Cell Count | 1 | 2011 | 323 | 0.090 |
Why?
| | Immunomodulation | 1 | 2011 | 98 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 514 | 0.080 |
Why?
| | Transforming Growth Factor beta | 2 | 2004 | 480 | 0.080 |
Why?
| | Stem Cells | 2 | 2012 | 593 | 0.080 |
Why?
| | Dendritic Cells | 1 | 2013 | 484 | 0.080 |
Why?
| | Vasodilator Agents | 1 | 2012 | 331 | 0.080 |
Why?
| | Cell Separation | 1 | 2011 | 318 | 0.080 |
Why?
| | Hyaluronic Acid | 1 | 2012 | 222 | 0.080 |
Why?
| | Ventricular Remodeling | 1 | 2012 | 262 | 0.080 |
Why?
| | Endothelial Cells | 1 | 2015 | 779 | 0.080 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 834 | 0.080 |
Why?
| | Arrhythmias, Cardiac | 1 | 2011 | 333 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2013 | 769 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2419 | 0.070 |
Why?
| | Infant | 2 | 2012 | 9451 | 0.070 |
Why?
| | Autoimmunity | 1 | 2013 | 908 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1759 | 0.070 |
Why?
| | Signal Transduction | 3 | 2013 | 5078 | 0.070 |
Why?
| | Child, Preschool | 2 | 2012 | 11080 | 0.070 |
Why?
| | Epigenesis, Genetic | 1 | 2011 | 659 | 0.060 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2005 | 15 | 0.060 |
Why?
| | Pneumonia | 1 | 2011 | 640 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2679 | 0.060 |
Why?
| | Young Adult | 2 | 2011 | 13163 | 0.060 |
Why?
| | Angiopoietins | 1 | 2003 | 13 | 0.050 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 34 | 0.050 |
Why?
| | Transcription Factors | 1 | 2012 | 1720 | 0.050 |
Why?
| | Herpesvirus 8, Human | 1 | 2003 | 65 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3568 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2002 | 767 | 0.050 |
Why?
| | Risk Factors | 1 | 2017 | 10368 | 0.050 |
Why?
| | Base Pair Mismatch | 1 | 2002 | 11 | 0.050 |
Why?
| | MutS Homolog 2 Protein | 1 | 2002 | 15 | 0.050 |
Why?
| | Herpesviridae Infections | 1 | 2003 | 149 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 64 | 0.050 |
Why?
| | Frameshift Mutation | 1 | 2002 | 32 | 0.050 |
Why?
| | Lymphokines | 1 | 2002 | 131 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 839 | 0.050 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2002 | 234 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2017 | 5753 | 0.040 |
Why?
| | Cattle | 2 | 2013 | 981 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2001 | 400 | 0.040 |
Why?
| | Cell Division | 1 | 2001 | 796 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2001 | 954 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2012 | 10800 | 0.030 |
Why?
| | Adult | 4 | 2019 | 37724 | 0.030 |
Why?
| | Base Sequence | 1 | 2001 | 2182 | 0.030 |
Why?
| | Listeriosis | 1 | 2017 | 70 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2017 | 193 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 976 | 0.030 |
Why?
| | Listeria monocytogenes | 1 | 2017 | 126 | 0.030 |
Why?
| | Blotting, Western | 2 | 2011 | 1226 | 0.030 |
Why?
| | Apoptosis | 2 | 2002 | 2554 | 0.030 |
Why?
| | Cell Line | 1 | 2001 | 2841 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 622 | 0.030 |
Why?
| | Stroke Volume | 1 | 2017 | 619 | 0.030 |
Why?
| | Macrophages | 2 | 2012 | 1544 | 0.030 |
Why?
| | DNA | 1 | 2001 | 1459 | 0.030 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2013 | 17 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 75 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 64 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 752 | 0.030 |
Why?
| | Immunoblotting | 1 | 2013 | 307 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 121 | 0.030 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 145 | 0.030 |
Why?
| | Vasa Vasorum | 1 | 2012 | 25 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 198 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 190 | 0.020 |
Why?
| | Caspase 1 | 1 | 2013 | 143 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2013 | 403 | 0.020 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 151 | 0.020 |
Why?
| | Connective Tissue | 1 | 2011 | 36 | 0.020 |
Why?
| | Interleukin-18 | 1 | 2013 | 237 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2017 | 827 | 0.020 |
Why?
| | Benzamides | 1 | 2012 | 217 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2013 | 372 | 0.020 |
Why?
| | Cell Cycle | 1 | 2013 | 601 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 346 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3009 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2011 | 201 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2011 | 467 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 474 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2012 | 442 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2011 | 844 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 33310 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5125 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 471 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 506 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2225 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1456 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2486 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1987 | 0.020 |
Why?
| | Densitometry | 1 | 2005 | 36 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 26 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2005 | 56 | 0.010 |
Why?
| | Prospective Studies | 1 | 2017 | 7595 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2005 | 219 | 0.010 |
Why?
| | Blood Pressure | 1 | 2012 | 1776 | 0.010 |
Why?
| | Epithelium | 1 | 2005 | 312 | 0.010 |
Why?
| | Bone Morphogenetic Protein Receptors | 1 | 2003 | 6 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4197 | 0.010 |
Why?
| | Species Specificity | 1 | 2005 | 585 | 0.010 |
Why?
| | Genes, Viral | 1 | 2003 | 88 | 0.010 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2003 | 51 | 0.010 |
Why?
| | Cyclins | 1 | 2003 | 91 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 867 | 0.010 |
Why?
| | Down-Regulation | 1 | 2005 | 658 | 0.010 |
Why?
| | Arteries | 1 | 2004 | 269 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 79 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 844 | 0.010 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 108 | 0.010 |
Why?
| | Hypertrophy | 1 | 2002 | 133 | 0.010 |
Why?
| | DNA, Viral | 1 | 2003 | 363 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2005 | 527 | 0.010 |
Why?
| | Viral Proteins | 1 | 2003 | 343 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2003 | 812 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2002 | 544 | 0.010 |
Why?
| | RNA | 1 | 2001 | 924 | 0.010 |
Why?
|
|
Yeager's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|